These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 11196691)
1. Targeting the mucosa: genetically engineered vaccines and mucosal immune responses. Stevceva L; Abimiku AG; Franchini G Genes Immun; 2000 Jun; 1(5):308-15. PubMed ID: 11196691 [TBL] [Abstract][Full Text] [Related]
2. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses. Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101 [TBL] [Abstract][Full Text] [Related]
3. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma. Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252 [TBL] [Abstract][Full Text] [Related]
4. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori. Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841 [TBL] [Abstract][Full Text] [Related]
5. Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses. Huang X; Liu L; Ren L; Qiu C; Wan Y; Xu J Vaccine; 2007 Dec; 25(52):8874-84. PubMed ID: 18061316 [TBL] [Abstract][Full Text] [Related]
6. Novel strategies using DNA for the induction of mucosal immunity. McCluskie MJ; Davis HL Crit Rev Immunol; 1999; 19(4):303-29. PubMed ID: 10530431 [TBL] [Abstract][Full Text] [Related]
7. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3. Kent SJ; Dale CJ; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Wilson KM; Ramsay AJ Vaccine; 2005 Oct; 23(42):5009-21. PubMed ID: 15985317 [TBL] [Abstract][Full Text] [Related]
8. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex. Garzón MR; Berraondo P; Crettaz J; Ochoa L; Vera M; Lasarte JJ; Vales A; Van Rooijen N; Ruiz J; Prieto J; Zulueta J; González-Aseguinolaza G Vaccine; 2005 Feb; 23(11):1384-92. PubMed ID: 15661387 [TBL] [Abstract][Full Text] [Related]
9. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus. Wang X; Zhang X; Kang Y; Jin H; Du X; Zhao G; Yu Y; Li J; Su B; Huang C; Wang B Vaccine; 2008 Sep; 26(40):5135-44. PubMed ID: 18462848 [TBL] [Abstract][Full Text] [Related]
12. Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria. Cortes-Perez NG; Lefèvre F; Corthier G; Adel-Patient K; Langella P; Bermúdez-Humarán LG Vaccine; 2007 Sep; 25(36):6581-8. PubMed ID: 17675182 [TBL] [Abstract][Full Text] [Related]
13. Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice. Guo L; Wang J; Zhou H; Si H; Wang M; Song J; Han B; Shu Y; Ren L; Qu J; Hung T Vaccine; 2008 Jan; 26(4):460-8. PubMed ID: 18160189 [TBL] [Abstract][Full Text] [Related]
14. Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera. Xu G; Wang S; Zhuang L; Hackett A; Gu L; Zhang L; Zhang C; Wang H; Huang Z; Lu S Vaccine; 2009 Jun; 27(29):3821-30. PubMed ID: 19443090 [TBL] [Abstract][Full Text] [Related]
15. Mucosal and systemic immunization with targeted fusion anti-caries DNA plasmid in young rats. Liu GX; Xu QA; Jin J; Li YH; Jia R; Guo JH; Fan MW Vaccine; 2009 May; 27(22):2940-7. PubMed ID: 19428904 [TBL] [Abstract][Full Text] [Related]
18. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines. Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465 [TBL] [Abstract][Full Text] [Related]
19. Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII. Ramanathan MP; Kutzler MA; Kuo YC; Yan J; Liu H; Shah V; Bawa A; Selling B; Sardesai NY; Kim JJ; Weiner DB Vaccine; 2009 Jul; 27(32):4370-80. PubMed ID: 19497647 [TBL] [Abstract][Full Text] [Related]
20. Protective immunity induced by systemic and mucosal delivery of DNA vaccine expressing glycoprotein B of pseudorabies virus. Yoon HA; Han YW; Aleyas AG; George JA; Kim SJ; Kim HK; Song HJ; Cho JG; Eo SK J Microbiol Biotechnol; 2008 Mar; 18(3):591-9. PubMed ID: 18388482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]